Dynamic Angiopoietin-2 assessment predicts clinical course of patients with SARS-CoV-2
The proinflammatory cytokine Angiopoietin-2 plays a key role in endothelial cell disruption and associated events. A recent study demonstrates that a three day change in Angiopoeitin-2 levels predicts the clinical course in hospital-mortality of patients with SARS-CoV-2. Angiopoietin-2 is a relevant part of disease pathogenesis and could be a target for new specific treatments in these patients.
Read more: Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with … Villa E et al., Blood Adv. 2021 Feb 9;5(3):662-673.
Angiopoietin-2 (ANG-2) can reliably be measured by ELISA in human serum, plasma and urine samples with Biomedica’s fully validated assay kit. Only 20 µl of sample volume is required! The kit incorporates ready to use standards and controls. The assay range is optimized for clinical samples- no sample dilution required!
Features & Benefits
√ Immediate results: no sample dilution required
√ Full validation package – the assay is optimized for clinical samples
√ Kit includes ready to use standards and controls
√ HIGH QUALITY GUARANTEED – https://buff.ly/3etWGHH
Find out more: Angiopoietin-2 ELISA